Oncology

Roche’s Tecentriq gets fourth European lung cancer indication

https://pharmaphorum.com/news/roches-tecentriq-gets-fourth-european-lung-cancer-indication/

Janssen files its first CAR-T therapy cilta-cel in Europe

https://pharmaphorum.com/news/janssen-files-its-first-car-t-therapy-cilta-cel-in-europe/

Keytruda should lose stomach cancer indication, says ODAC

https://pharmaphorum.com/news/keytruda-should-lose-stomach-cancer-indication-says-odac/

Tecentriq can stay as therapy for triple-negative breast cancer, FDA experts say

https://pharmaphorum.com/news/tecentriq-can-stay-as-therapy-for-triple-negative-breast-cancer-fda-experts-say/

FDA looks at pulling speedy approvals for three cancer drugs

https://pharmaphorum.com/news/fda-looks-at-pulling-speedy-approvals-for-three-cancer-drugs/

J&J decides against Erleada+Zytiga combination prostate cancer filing

https://pharmaphorum.com/news/jj-decides-against-erleadazytiga-combination-prostate-cancer-filing/

Astellas, Seagen seek speedy reviews of Padcev in bladder cancer

https://pharmaphorum.com/news/astellas-seagen-seek-speedy-reviews-of-padcev-in-bladder-cancer/

Non-Small Cell Lung Cancer Drug Development Summit

https://pharmaphorum.com/events/non-small-cell-lung-cancer-drug-development-summit/

Boehringer and MD Anderson extend KRAS cancer collaboration

https://pharmaphorum.com/news/boehringer-and-md-anderson-extend-kras-cancer-collaboration/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search